Liquid Biotech

About:

Liquid Biotech is a technology for cancer diagnostics and gene discover

Website: http://www.liquidbiotechusa.com

Description:

Liquid Biotech is a developer of non-invasive blood tests for cancer. With the company's method, serial biopsies can be performed with little risk, live cancer cells can be isolated, and the genetic information from those cells can be used by the oncologist to guide therapy (personalized medicine). Cancer diagnosis and prognosis, as well as the emergence of therapeutic resistance mechanisms, are just a few of the many topics covered by Liquid Biotech's technology.

Total Funding Amount:

$2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Philadelphia, Pennsylvania, United States

Founded Date:

2012-01-01

Founders:

Gary Kao, Jay Dorsey, Stephen Hahn

Number of Employees:

1-10

Last Funding Date:

2015-12-02

IPO Status:

Private

Industries:

© 2025 bioDAO.ai